Nelson, Sean A.
Richards, Katherine A.
Glover, Maryah A. http://orcid.org/0000-0001-7505-2583
Chaves, Francisco A. http://orcid.org/0000-0002-2818-2526
Crank, Michelle C.
Graham, Barney S.
Kanekiyo, Masaru http://orcid.org/0000-0001-5767-1532
Sant, Andrea J. http://orcid.org/0000-0001-7176-7426
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (HHSN272201400005C, HHSN272201400005C-16I, 75N93019C00052, R21AI145269)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (5T32HL066988-19)
Article History
Received: 2 June 2022
Accepted: 6 October 2022
First Online: 26 October 2022
Competing interests
: M.K. and B.S.G. are named inventors on patent pending applications involving influenza vaccines. M.K. and B.S.G. are named inventors of US patent 9,441,019 titled Influenza Hemagglutinin Protein-based Vaccines. The remaining authors declare no competing interests.